Finance

Lists
XRAY:NASDAQ
DENTSPLY SIRONA Inc
၁၁.၃၈ US$
-၀.၄၄%
(-၀.၀၅၀) 1D
၁၁.၃၈ US$
၀.၀၀% (၀.၀၀)
Pre-market
Closed: စက် ၄, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XRAY...
Open
၁၁.၂၉ US$
High
၁၁.၅၃ US$
Low
၁၁.၂၀ US$
Mkt. cap
၂၂၆.၈၆ ဋေ
Avg. vol.
၄.၃၀ သန်း
Volume
၁၀၀.၀၀
52-wk high
၁၄.၈၆ US$
52-wk low
၉.၄၁ US$
EPS
-၂.၇၄ US$
Beta
၀.၈၄
Shares outstanding
၁၉.၉၄ ကုဋေ
No. of employees
၁ သောင်း
Open
၁၁.၂၉ US$
High
၁၁.၅၃ US$
Low
၁၁.၂၀ US$
Mkt. cap
၂၂၆.၈၆ ဋေ
Avg. vol.
၄.၃၀ သန်း
Volume
၁၀၀.၀၀
52-wk high
၁၄.၈၆ US$
52-wk low
၉.၄၁ US$
EPS
-၂.၇၄ US$
Beta
၀.၈၄
Shares outstanding
၁၉.၉၄ ကုဋေ
No. of employees
၁ သောင်း
Profile
Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million. As an equipment maker, it designs and manufactures laboratory and specialty products relating to dental supplies. With regard to consumable products, it specializes in anesthetics, plaque and gum disease prevention and tooth polishers. It also designs and constructs artificial teeth. It has also been cited as a key player in the future intra-oral flat panel sensor market. Because of the income disparity between wealthy and developing nations, the variety of products in demand differs from region to region. On August 28, 2022, Dentsply Sirona announced the appointment of Simon D. Campion, formerly Executive Vice President and President of the Interventional segment for BD, as President and Chief Executive Officer and a member of the board. In 2018 a Netherlands-based certification company awarded Dentsply the “Top Employer” certification. Wikipedia
About DENTSPLY SIRONA Inc
CEODaniel T. Scavilla
Employees၁.၄ သောင်း
Founded၂၀၁၆
Headquarters-
Sector-
Analyst ratings
Based on 12 analysts giving stock ratings to XRAY in the past 3 months
Hold
Buy
2
Hold
9
Sell
1
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for XRAY in the last 3 months.
Highest
Current ၁၁.၃၈ US$
၁၇.၀၀ US$ (+၄၉.၃၈%)
Average
၁၄.၁၃ US$ (+၂၄.၁၇%)
Lowest
၁၁.၀၀ US$ (-၃.၃၄%)
Analyst
Recommendation
Action
Price target
Projected
Date
Glen Santangelo
Barclays
Sell
Maintained
၁၁.၀၀ US$
-၃.၃%
08/21/2026
Michael Petusky
Barrington
Buy
Maintained
၁၅.၀၀ US$
+၃၁.၈%
08/10/2026
Jonathan Block
Stifel Nicolaus
Hold
Maintained
၁၄.၀၀ US$
+၂၃%
08/07/2026
Elizabeth Anderson CFA
Evercore ISI
Hold
Maintained
၁၄.၀၀ US$
+၂၃%
08/07/2026
Vik Chopra
BMO Capital
Hold
Maintained
၁၃.၀၀ US$
+၁၄.၂%
08/06/2026
Jason Bednar
Piper Sandler
Hold
Reiterated
၁၄.၀၀ US$
+၂၃%
08/07/2026
Jeff Johnson
Robert W. Baird
Hold
Maintained
၁၅.၀၀ US$
+၃၁.၈%
08/07/2026
Brandon Vazquez
William Blair
Hold
Maintained
-
-
08/07/2026
David Saxon
Needham
Hold
Maintained
-
-
08/07/2026
Erin Wright
Morgan Stanley
Hold
Maintained
-
-
07/24/2026
Unknown Analyst
BMO Capital
Hold
Initiated
၁၂.၀၀ US$
+၅.၄%
07/09/2026
Michael Cherny
Leerink Partners
Hold
Maintained
-
-
06/12/2026
Allen Lutz
Bank of America Securities
Buy
Maintained
၁၇.၀၀ US$
+၄၉.၄%
06/11/2026
Kevin Caliendo
UBS
Buy
Maintained
၁၇.၀၀ US$
+၄၉.၄%
05/07/2026
Steven Valiquette
Mizuho Securities
Hold
Maintained
၁၄.၀၀ US$
+၂၃%
05/06/2026
Daniel Grosslight
Citi
Sell
Maintained
၁၀.၅၀ US$
-၇.၇%
05/06/2026
Unknown Analyst
Wells Fargo
Hold
Maintained
၁၃.၀၀ US$
+၁၄.၂%
02/27/2026
Last report
၂၀၂၆ ဩ ၆
Fiscal period
Q2 2026
EPS / Est. (USD)
၀.၅၂ US$ / ၀.၃၅ US$
+၄၉.၈၉%beat
Revenue / Est. (USD)
၈၉.၈၀ ကုဋေ / ၈၈.၉၀ ကုဋေ
+၁.၀၂%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၉၀.၄၀ ကုဋေ
၉၆.၁၀ ကုဋေ
၈၈.၀၀ ကုဋေ
၈၉.၈၀ ကုဋေ
Cost of goods sold
၄၆.၃၀ ကုဋေ
၅၁.၈၀ ကုဋေ
၄၅.၃၀ ကုဋေ
၄၀.၅၀ ကုဋေ
Cost of revenue
၄၆.၃၀ ကုဋေ
၅၁.၈၀ ကုဋေ
၄၅.၃၀ ကုဋေ
၄၀.၅၀ ကုဋေ
Research and development expenses
၃.၇၀ ကုဋေ
၄.၀၀ ကုဋေ
၄.၄၀ ကုဋေ
၄.၅၀ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃၅.၈၀ ကုဋေ
၃၈.၆၀ ကုဋေ
၃၅.၃၀ ကုဋေ
၃၆.၅၀ ကုဋေ
Operating expense
၃၉.၅၀ ကုဋေ
၄၂.၆၀ ကုဋေ
၃၉.၇၀ ကုဋေ
၄၁.၀၀ ကုဋေ
Total operating expenses
၈၅.၈၀ ကုဋေ
၉၄.၄၀ ကုဋေ
၈၅.၀၀ ကုဋေ
၈၁.၅၀ ကုဋေ
Operating income
၄.၆၀ ကုဋေ
၁.၇၀ ကုဋေ
၃.၀၀ ကုဋေ
၈.၃၀ ကုဋေ
Other non operating income
၁.၀၀ သန်း
-၂.၀၀ သန်း
၆.၀၀ သန်း
-
EBT including unusual items
-၂၃.၀၀ ကုဋေ
-၁၄.၇၀ ကုဋေ
-၄.၂၀ ကုဋေ
၇.၂၀ ကုဋေ
EBT excluding unusual items
၃.၇၀ ကုဋေ
၁.၂၀ ကုဋေ
၂.၅၀ ကုဋေ
၇.၄၀ ကုဋေ
Income tax expense
၁၉.၈၀ ကုဋေ
-၂.၀၀ သန်း
-၃.၂၀ ကုဋေ
၃.၆၀ ကုဋေ
Effective tax rate
-၈၆.၀၉%
၁.၃၆%
၇၆.၁၉%
၅၀.၀၀%
Other operating expenses
-
-
-
-
Net income
-၄၂.၇၀ ကုဋေ
-၁၄.၆၀ ကုဋေ
-၁.၀၀ ကုဋေ
၃.၇၀ ကုဋေ
Net profit margin
-၄၇.၂၃%
-၁၅.၁၉%
-၁.၁၄%
၄.၁၂%
Earnings per share
၀.၃၇
၀.၂၇
၀.၂၇
၀.၅၂
Interest and investment income
၃.၀၀ သန်း
၄.၀၀ သန်း
-
၄.၀၀ သန်း
Interest expense
-၂.၆၀ ကုဋေ
-၂.၆၀ ကုဋေ
-၂.၄၀ ကုဋေ
-၂.၆၀ ကုဋေ
Net interest expenses
-၂.၃၀ ကုဋေ
-၂.၂၀ ကုဋေ
-၂.၄၀ ကုဋေ
-၂.၂၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၁၃.၈၀ ကုဋေ
၁၁.၀၀ ကုဋေ
၁၀.၉၀ ကုဋေ
၁၆.၈၀ ကုဋေ
Gain or loss from assets sale
-
-
-၆.၀၀ သန်း
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ